Abstract:Background: The use of iodine-based contrast agent for better delineation of tumors in breast CT (bCT) has been shown to be compelling, similar to the tumor enhancement in contrast-enhanced breast MRI. Contrast-enhanced bCT (CE-bCT) is a relatively new tool, and a structured evaluation of different imaging parameters at play has yet to be conducted. In this investigation, data sets of acquired bCT images from 253 patients imaged at our institution were used in concert with simulated mathematically inserted spherical contrast-enhanced lesions to study the role of contrast enhancement on detectability. Purpose: To quantitatively evaluate the improvement in lesion detectability due to contrast enhancement across lesion diameter, section thickness, view plane, and breast density using a pre-whitened matched filter (PWMF) model observer. Methods: The relationship between iodine concentration and Hounsfield units (HU) was measured using spectral modeling. The lesion enhancement from clinical CE-bCT images in 22 patients was evaluated, and the average contrast enhancement (ΔHU) was determined. Mathematically generated spherical mass lesions of varying diameters (1, 3, 5, 9, 11, 15 mm) and contrast enhancement levels (0, 0.25, 0.50, 0.75, 1) were inserted at random locations in 253 actual patient bCT datasets. Images with varying thicknesses (0.4-19.8 mm) were generated by slice averaging, and the role of view plane (coronal and axial planes) was studied. A PWMF was used to generate receiver operating characteristic (ROC) curves across parameters of lesion diameter, contrast enhancement, section thickness, view plane, and breast density. The area under the ROC curve (AUC) was used as the primary performance metric, generated from over 90,000 simulated lesions. Results: An average 20% improvement (ΔAUC = 0.1) in lesion detectability due to contrast enhancement was observed across lesion diameter, section thickness, breast density, and view plane. A larger improvement was observed when stratifying patients based on breast density. For patients with VGF ≤ 40%, detection performance improved up to 20% (until AUC →1), and for patients with denser breasts (VGF > 40%), detection performance improved more drastically, ranging from 20% to 80% for 1- and 5-mm lesions. For the 1 mm lesion, detection performance raised slightly at the 1.2 mm section thickness before falling off as thickness increased. For larger lesions, detection performance was generally unaffected as section thickness increased up until it reached 5.8 mm, where performance began to decline. Detection performance was higher in the axial plane compared to the coronal plane for smaller lesions and thicker sections. Conclusions: For emerging diagnostic tools like CE-bCT, it is important to optimize imaging protocols for lesion detection. In this study, we found that intravenous contrast can be used to detect small lesions in dense breasts. Optimal section thickness for detectability has dependencies on breast density and lesion size, therefore, display thickness should be adjusted in real-time using display software. These findings may be useful for the development of CE-bCT as well as other x-ray-based breast imaging modalities.

Towards improved lesion quantification and volume estimation with contrast-enhanced digital breast tomosynthesis using convolutional neural networks: a simulation study

Experimental validation of a three-dimensional linear system model for breast tomosynthesis.

Model-based deep CNN-regularized reconstruction for digital breast tomosynthesis with a task-based CNN image assessment approach

Convolutional Neural Network to Restore Low-Dose Digital Breast Tomosynthesis Projections in a Variance Stabilization Domain

Assessing Breast Cancer Volume Alterations Post-Neoadjuvant Chemotherapy Through DenseNet-201 Deep Learning Analysis on DCE-MRI

Deep learning reconstruction of digital breast tomosynthesis images for accurate breast density and patient-specific radiation dose estimation

Lesion Attention Guided Neural Network for Contrast-Enhanced Mammography-based Biomarker Status Prediction in Breast Cancer

Computed Tomography Image Enhancement Using 3d Convolutional Neural Network

Model observer performance in contrast-enhanced lesions in breast CT: The influence of contrast concentration on detectability

Use of clinical MRI maximum intensity projections for improved breast lesion classification with deep convolutional neural networks

CoMoTo: Unpaired Cross-Modal Lesion Distillation Improves Breast Lesion Detection in Tomosynthesis

Lesion detection in contrast enhanced spectral mammography

Digital mammographic tumor classification using transfer learning from deep convolutional neural networks

Virtual dynamic contrast enhanced breast MRI using 2D U-Net Architectures.

Breast Cancer Diagnosis in Digital Breast Tomosynthesis: Effects of Training Sample Size on Multi-Stage Transfer Learning Using Deep Neural Nets

Improved Digital Breast Tomosynthesis Images Using Automated Ultrasound

Quantitative Imaging of Iodine-Based Contrast Agent in Dual-Energy DBT

Deep-learning-based projection-domain breast thickness estimation for shape-prior iterative image reconstruction in digital breast tomosynthesis

Simulating Dynamic Tumor Contrast Enhancement in Breast MRI using Conditional Generative Adversarial Networks

Lesion Detection in Breast Tomosynthesis Using Efficient Deep Learning and Data Augmentation Techniques

Digital Breast Tomosynthesis for Upgraded BIRADS Scoring towards the True Pathology of Lesions Detected by Contrast-Enhanced Mammography